These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27544552)

  • 41. Nanoparticles for transcutaneous vaccination.
    Hansen S; Lehr CM
    Microb Biotechnol; 2012 Mar; 5(2):156-67. PubMed ID: 21854553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcutaneous immunization and immunostimulant strategies.
    Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microneedle-Based Vaccine Delivery: Review of an Emerging Technology.
    Mansoor I; Eassa HA; Mohammed KHA; Abd El-Fattah MA; Abdo MH; Rashad E; Eassa HA; Saleh A; Amin OM; Nounou MI; Ghoneim O
    AAPS PharmSciTech; 2022 Apr; 23(4):103. PubMed ID: 35381906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination.
    Feng YX; Hu H; Wong YY; Yao X; He ML
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microneedle patches for vaccine delivery.
    Suh H; Shin J; Kim YC
    Clin Exp Vaccine Res; 2014 Jan; 3(1):42-9. PubMed ID: 24427762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanoparticulate mediated transcutaneous immunization: Myth or reality.
    Kaurav M; Minz S; Sahu K; Kumar M; Madan J; Pandey RS
    Nanomedicine; 2016 May; 12(4):1063-1081. PubMed ID: 26767517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vesicular carrier constructs for topical immunisation.
    Vyas SP; Khatri K; Mishra V
    Expert Opin Drug Deliv; 2007 Jul; 4(4):341-8. PubMed ID: 17683248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microneedles for Transdermal Biosensing: Current Picture and Future Direction.
    Ventrelli L; Marsilio Strambini L; Barillaro G
    Adv Healthc Mater; 2015 Dec; 4(17):2606-40. PubMed ID: 26439100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal immunomodulation: Principles, advances and perspectives.
    Zhao Z; Ukidve A; Dasgupta A; Mitragotri S
    Adv Drug Deliv Rev; 2018 Mar; 127():3-19. PubMed ID: 29604373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
    Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
    Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
    Chen MC; Huang SF; Lai KY; Ling MH
    Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.
    Scheiblhofer S; Thalhamer J; Weiss R
    Expert Opin Drug Deliv; 2013 Jun; 10(6):761-73. PubMed ID: 23425032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal drug delivery.
    Prausnitz MR; Langer R
    Nat Biotechnol; 2008 Nov; 26(11):1261-8. PubMed ID: 18997767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
    Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.